U.S. flag

An official website of the United States government

NM_001077415.3(CRELD1):c.658C>T (p.Arg220Ter) AND Atrioventricular septal defect, susceptibility to, 2

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Dec 28, 2020
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001196762.5

Allele description

NM_001077415.3(CRELD1):c.658C>T (p.Arg220Ter)

Gene:
CRELD1:cysteine rich with EGF like domains 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p25.3
Genomic location:
Preferred name:
NM_001077415.3(CRELD1):c.658C>T (p.Arg220Ter)
HGVS:
  • NC_000003.12:g.9941131C>T
  • NG_017069.1:g.12291C>T
  • NM_001031717.4:c.658C>T
  • NM_001077415.3:c.658C>TMANE SELECT
  • NM_001374316.1:c.658C>T
  • NM_001374317.1:c.658C>T
  • NM_001374318.1:c.658C>T
  • NM_001374319.1:c.658C>T
  • NM_001374320.1:c.658C>T
  • NM_015513.6:c.658C>T
  • NP_001026887.2:p.Arg220Ter
  • NP_001070883.2:p.Arg220Ter
  • NP_001361245.1:p.Arg220Ter
  • NP_001361246.1:p.Arg220Ter
  • NP_001361247.1:p.Arg220Ter
  • NP_001361248.1:p.Arg220Ter
  • NP_001361249.1:p.Arg220Ter
  • NP_056328.3:p.Arg220Ter
  • NC_000003.11:g.9982815C>T
  • NC_000003.11:g.9982815C>T
  • NM_001031717.3:c.658C>T
  • NR_164475.1:n.686C>T
  • NR_164476.1:n.662C>T
  • NR_164477.1:n.1036C>T
Protein change:
R220*
Links:
dbSNP: rs1433259474
NCBI 1000 Genomes Browser:
rs1433259474
Molecular consequence:
  • NR_164475.1:n.686C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_164476.1:n.662C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_164477.1:n.1036C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NM_001031717.4:c.658C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001077415.3:c.658C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001374316.1:c.658C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001374317.1:c.658C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001374318.1:c.658C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001374319.1:c.658C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001374320.1:c.658C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_015513.6:c.658C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Atrioventricular septal defect, susceptibility to, 2
Synonyms:
Atrioventricular septal defect 2
Identifiers:
MONDO: MONDO:0011650; MedGen: C1853508; OMIM: 606217

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001367395Centre for Mendelian Genomics, University Medical Centre Ljubljana
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Nov 22, 2019)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002272862Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Dec 28, 2020)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Centre for Mendelian Genomics, University Medical Centre Ljubljana, SCV001367395.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PM2,PP3.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

From Invitae, SCV002272862.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals with CRELD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 930822). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Arg220*) in the CRELD1 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in CRELD1 cause disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 28, 2024